New African Partners join the AntiMal Consortium

The AntiMal consortium has expanded to 34 partners with the integration of three new partners from Africa:

1. The Council for Scientific and Industrial Research (CSIR), based in South Africa is one of the leading research and development, technology and innovation institutions in Africa. CSIR Biosciences will conduct research into novel antimalarials from natural products. The Principle Investigator (PI) of this group is Dr Chris Parkinson.

2. The Kenya Medical Research Institute (KEMRI) group under the leadership of Dr Alexis Nzila represents international expertise in antifolate antimalarial drugs with a proven record in molecular and biochemical studies as well as field investigations. His research has been used to fight malaria in Kenya and Nigeria.

3. Dr Maina Ngotho from The Institute of Primate Research (IPR) will be work with Dr Nzila from KEMRI on a new work package to investigate novel antifolates as anitmalarial agents.

The EU contribution to the AntiMal consortium will increase by 250,000 Euros as a result of these new initiatives.


CSIR Team with Dr Chris Parkinson - Back row far right	KEMRI Team with Dr Alexis Nzila - Second from right	IPR Team with Dr Maina Ngotho - Second Left